/افقی تازه در درمان سرطان/۲

یکشنبه 18 آذر‌ماه سال 1386 ساعت 09:43 ق.ظ

Dr. Omid Farokhzad, Assistant Professor, Harvard Medical School (HMS)
Dr. Omid Farokhzad is a practicing physician in the Department of Anesthesiology at Brigham and Women's Hospital (BWH). He is a graduate of Boston University School of Medicine and completed his post-graduate clinical and research training, respectively, at BWH/HMS and at the laboratory of Professor Robert Langer at MIT. Dr. Farokhzad has pioneered the application of micro- and .

nanotechnologies for high throughput development and screening of targeted drug delivery systems for a myriad of clinical applications - most notably cancer. His research group is focused on the development and engineering of smart nanoparticles for therapeutic and diagnostic applications. Other areas of focus include drug target identification and validation; and high throughput synthesis and screening of nanomaterials for drug delivery. Recent work from Dr. Farokhzad's group includes the development of targeted nanoparticles capable of recognizing prostate cancer specifically and these were able to eradicate tumors in mouse models of prostate cancer. More recently they have developed "smart" targeted nanopariticles capable of delivering drugs to prostate cancer cells while simultaneously imaging the cancer location. These newer generation nanoparticles were also engineered to have a reporter component allowing them to signal when they had delivered their therapeutic payload. Dr. Farokhzad's work has been the subject of extensive press coverage including approximately 200 written articles and being featured on the cover of Popular Science. Forbes featured Dr. Farokhzad’s work as of its top 5 nanotechnology breakthroughs of 2006. Dr. Farokhzad has authored approximately 30 publications and is an inventor on 20 patent applications

del.icio.us  digg  newsvine  furl  Y!  smarking  segnalo